Particulate and cytosolic protein tyrosine phosphatase (PTPase) activity was measured in skeletal muscle from 15 insulin-sensitive subjects and 5 insulin-resistant nondiabetic subjects, as well as 18 subjects with non-insulin-dependent diabetes mellitus (NIDDM). Approximately 90% of total PTPase activity resided in the particulate fraction. In comparison with lean nondiabetic subjects, particulate PTPase activity was reduced 21% (P < 0.05) and 22% (P < 0.005) in obese nondiabetic and NIDDM subjects, respectively. PTPase1B protein levels were likewise decreased by 38% in NIDDM subjects (P < 0.05). During hyperinsulinemic glucose clamps, glucose disposal rates (GDR) increased approximately sixfold in lean control and twofold in NIDDM subjects, while particulate PTPase activity did not change. However, a strong positive correlation (r = 0.64, P < 0.001) existed between particulate PTPase activity and insulin-stimulated GDR. In five obese NIDDM subjects, weight loss of approximately 10% body wt resulted in a significant and corresponding increase in both particulate PTPase activity and insulin-stimulated GDR. These findings indicate that skeletal muscle particulate PTPase activity and PTPase1B protein content reflect in vivo insulin sensitivity and are reduced in insulin resistant states. We conclude that skeletal muscle PTPase activity is involved in the chronic, but not acute regulation of insulin action, and that the decreased enzyme activity may have a role in the insulin resistance of obesity and NIDDM.
J Kusari, K A Kenner, K I Suh, D E Hill, R R Henry
Title and authors | Publication | Year |
---|---|---|
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer
JA Janssen |
International journal of molecular sciences | 2021 |
Exercise Counterbalances Rho/ROCK2 Signaling Impairment in the Skeletal Muscle and Ameliorates Insulin Sensitivity in Obese Mice
VR Muñoz, RC Gaspar, MB Severino, AP Macêdo, FM Simabuco, ER Ropelle, DE Cintra, AS da Silva, YB Kim, JR Pauli |
Frontiers in immunology | 2021 |
Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B)
J Jin, X Ye, D Boateng, K Dai, F Ye, P Du, H Yu |
Bioorganic & Medicinal Chemistry Letters | 2019 |
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
W Chen, E Balland, MA Cowley |
Neuroendocrinology | 2017 |
A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma
RM Furnica, L Istasse, D Maiter |
Annales d'Endocrinologie | 2017 |
Inhibitory evaluation of oligonol on α-glucosidase, protein tyrosine phosphatase 1B, cholinesterase, and β-secretase 1 related to diabetes and Alzheimer’s disease
JS Choi, HK Bhakta, H Fujii, BS Min, CH Park, T Yokozawa, HA Jung |
Archives of Pharmacal Research | 2016 |
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider |
Principles of Diabetes Mellitus | 2016 |
In vitro antidiabetic potential of the fruits of Crataegus pinnatifida
S S Chowdhury, M N Islam, H A Jung, J S Choi |
Research in Pharmaceutical Sciences | 2015 |
Anti-Diabetic and Anti-Inflammatory Potential of the Edible Brown Alga H izikia Fusiformis: Anti-Diabetic and Anti-Inflammatory Activities of Hizikia Fusiformis
YR Han, MY Ali, MH Woo, HA Jung, JS Choi |
Journal of Food Biochemistry | 2015 |
VMH Ptpn1 Deletion Unexpectedly Exacerbates High-Fat-Diet-Induced Obesity in Female Mice
Franck Chiappini, Karyn Catalano, Jennifer Lee, Odile Peroni, Jacqueline Lynch, Abha Dhaneshwar, Kerry Wellenstein, Alexandra Sontheimer, Benjamin G Neel, Barbara Kahn |
Journal of Clinical Investigation | 2014 |
Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B
H Ding, Y Zhang, C Xu, D Hou, J Li, Y Zhang, W Peng, K Zen, CY Zhang, X Jiang |
Diabetologia | 2014 |
Anti-Diabetic and Anti-Inflammatory Effects of Green and Red Kohlrabi Cultivars (Brassica oleracea var. gongylodes)
HA Jung, S Karki, NY Ehom, MH Yoon, EJ Kim, JS Choi |
Preventive Nutrition and Food Science | 2014 |
Development of endometrial carcinoma in a patient with leprechaunism (donohue syndrome)
W Jo, S Sudo, A Nakamura, D Endo, Y Konno, K Ishizu, T Tajima |
Clinical Pediatric Endocrinology | 2013 |
Leptin signaling in skeletal muscle after bed rest in healthy humans
B Guerra, JG Ponce-González, D Morales-Alamo, A Guadalupe-Grau, K Kiilerich, T Fuentes, S Ringholm, RS Biensø, A Santana, C Lundby, H Pilegaard, JA Calbet |
European Journal of Applied Physiology | 2013 |
Protein Tyrosine Phosphatase Control of Metabolism
KK Bence |
2013 | |
Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans
AJ Stull, ZQ Wang, XH Zhang, Y Yu, WD Johnson, WT Cefalu |
Diabetes | 2012 |
Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes: Relationship between disordered insulin secretion and insulin resistance
CJ Schofield, C Sutherland |
Diabetic Medicine | 2012 |
Accounting of ligand-receptor interactions to explore and design novel architecture for PTP 1B inhibition: a legitimate approach: Accounting of ligand-receptor interactions
P Malla, R Kumar, M Kumar |
Journal of Chemometrics | 2012 |
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal |
The Metabolic Syndrome | 2011 |
Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats
IM Liu, JT Cheng |
Evidence-Based Complementary and Alternative Medicine | 2011 |
An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice
ZQ Wang, D Ribnicky, XH Zhang, A Zuberi, I Raskin, Y Yu, WT Cefalu |
The Journal of Nutritional Biochemistry | 2011 |
Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome?
KK Bence |
Journal of clinical metabolism & diabetes | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Leptin receptor 170 kDa (OB-R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance: Leptin receptors in obese humans
T Fuentes, I Ara, A Guadalupe-Grau, S Larsen, B Stallknecht, H Olmedillas, A Santana, JW Helge, JA Calbet, B Guerra |
Experimental Physiology | 2009 |
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo
JM Zabolotny, YB Kim, LA Welsh, EE Kershaw, BG Neel, BB Kahn |
The Journal of biological chemistry | 2008 |
Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?
MH Shanik, Y Xu, J Skrha, R Dankner, Y Zick, J Roth |
2008 | |
Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo
JM Zabolotny, YB Kim, LA Welsh, EE Kershaw, BG Neel, BB Kahn |
The Journal of biological chemistry | 2008 |
Modulation of Protein Tyrosine Phosphatase 1B by Erythropoietin in UT-7 Cell Line
M Callero, G Pérez, D Vittori, N Pregi, A Nesse |
Cellular Physiology and Biochemistry | 2007 |
Increased insulin-stimulated Akt pSer 473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training
GD Wadley, N Konstantopoulos, L Macaulay, KF Howlett, A Garnham, M Hargreaves, D Cameron-Smith |
Journal of applied physiology | 2007 |
Increased Hypothalamic Protein Tyrosine Phosphatase 1B Contributes to Leptin Resistance with Age
CD Morrison, CL White, Z Wang, SY Lee, DS Lawrence, WT Cefalu, ZY Zhang, TW Gettys |
Endocrinology | 2007 |
Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats
Y Wu, JP Ouyang, K Wu, SS Wang, CY Wen, ZY Xia |
British Journal of Pharmacology | 2005 |
Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B1
Y WU, J OU-YANG, K WU, Y WANG, Y ZHOU, C WEN |
Acta Pharmacologica Sinica | 2005 |
The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population
I Gouni-Berthold, E Giannakidou, D Muller-Wieland, M Faust, J Kotzka, HK Berthold, W Krone |
Journal of Internal Medicine | 2005 |
Cardiac resistance to growth hormone in uremia
Z Zheng, DF Sun, P Tummala, R Rabkin |
Kidney International | 2005 |
Recent advances in protein tyrosine phosphatase 1B inhibitors
SD Taylor, B Hill |
Expert Opinion on Investigational Drugs | 2004 |
Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors
CK Lau, CI Bayly, JY Gauthier, CS Li, M Therien, E Asante-Appiah, W Cromlish, Y Boie, F Forghani, S Desmarais, Q Wang, K Skorey, D Waddleton, P Payette, C Ramachandran, BP Kennedy, G Scapin |
Bioorganic & Medicinal Chemistry Letters | 2004 |
PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity
ZY Zhang, SY Lee |
Expert Opinion on Investigational Drugs | 2003 |
Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor
JF Théberge, MZ Mehdi, SK Pandey, AK Srivastava |
Archives of Biochemistry and Biophysics | 2003 |
Protein-tyrosine-phosphatase 1B activation is regulated developmentally in muscle of neonatal pigs
A Suryawan, TA Davis |
American journal of physiology. Endocrinology and metabolism | 2003 |
Structure-based prediction of free energy changes of binding of PTP1B inhibitors
J Wang, SL Chan, K Ramnarayan |
Journal of Computer-Aided Molecular Design | 2003 |
3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors
VS Murthy, VM Kulkarni |
Bioorganic & Medicinal Chemistry | 2002 |
Molecular Modeling of Protein Tyrosine Phosphatase 1B (PTP 1B) Inhibitors
VS Murthy, VM Kulkarni |
Bioorganic & Medicinal Chemistry | 2002 |
Effects of troglitazone on skeletal muscle and liver protein tyrosine phosphatase activity in insulin-resistant otsuka long-evans tokushima fatty rats
T Seiichi, S Shinji, H Toshiro, Y Haruhiko, H Hideaki, O Kosei, N Masaharu, I Hajime |
Current Therapeutic Research | 2002 |
Tumour Necrosis Factor-α Levels in Non-Diabetic Offspring of Patients with Type 2 Diabetes Mellitus
E Maltezos, D Papazoglou, T Exiara, L Papazoglou, E Karathanasis, D Christakidis, S Ktenidou-Kartali |
J INT MED RES | 2002 |
Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities
O Ukkola, M Santaniemi |
Journal of Internal Medicine | 2002 |
Investigation of Potential Bioisosteric Replacements for the Carboxyl Groups of Peptidomimetic Inhibitors of Protein Tyrosine Phosphatase 1B: Identification of a Tetrazole-Containing Inhibitor with Cellular Activity
C Liljebris, SD Larsen, D Ogg, BJ Palazuk, JE Bleasdale |
Journal of Medicinal Chemistry | 2002 |
Effects of adenovirus-mediated liver-selective overexpression of protein tyrosine phosphatase-1b on insulin sensitivityin vivo
J Wang, AT Cheung, JK Kolls, WW Starks, A Martinez-Hernandez, D Dietzen, M Bryer-Ash |
Diabetes, Obesity and Metabolism | 2001 |
Development of a Robust Scintillation Proximity Assay for Protein Tyrosine Phosphatase 1B Using the Catalytically Inactive (C215S) Mutant
KI Skorey, BP Kennedy, RW Friesen, C Ramachandran |
Analytical Biochemistry | 2001 |
A P387L Variant in Protein Tyrosine Phosphatase-1B (PTP-1B) Is Associated With Type 2 Diabetes and Impaired Serine Phosphorylation of PTP-1B In Vitro
SM Echwald, H Bach, H Vestergaard, B Richelsen, K Kristensen, T Drivsholm, K Borch-Johnsen, T Hansen, O Pedersen |
Diabetes | 2001 |
Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)
B Lu, D Ennis, R Lai, E Bogdanovic, R Nikolov, L Salamon, C Fantus, H Le-Tien, IG Fantus |
The Journal of biological chemistry | 2001 |
Pulling Strings Below the Surface: Hormone Receptor Signaling Through Inhibition of Protein Tyrosine Phosphatases
X Espanel, S Wälchli, RP Gobert, ME Alama, ML Curchod, N Gullu-Isler, RH van Huijsduijnen |
Endocrine | 2001 |
Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor
S Dadke, A Kusari, J Kusari |
Molecular and Cellular Biochemistry | 2001 |
Protein tyrosine phosphatase-1B in diabetes
B Kennedy |
Biochemical Pharmacology | 2000 |
Calorie restriction increases insulin-stimulated tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 in rat skeletal muscle
Dean, Cartee |
Acta Physiologica Scandinavica | 2000 |
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
LD Klaman, O Boss, OD Peroni, JK Kim, JL Martino, JM Zabolotny, N Moghal, M Lubkin, YB Kim, AH Sharpe, A Stricker-Krongrad, GI Shulman, BG Neel, BB Kahn |
Molecular and cellular biology | 2000 |
Elevated Expression and Activity of Protein-Tyrosine Phosphatase 1B in Skeletal Muscle of Insulin-Resistant Type II Diabetic Goto-Kakizaki Rats
SS Dadke, HC Li, AB Kusari, N Begum, J Kusari |
Biochemical and Biophysical Research Communications | 2000 |
Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus
J Shao, PM Catalano, H Yamashita, T Ishizuka, JE Friedman |
American Journal of Obstetrics and Gynecology | 2000 |
Obesity: Pathology and Therapy
DH Lockwood, TC Heffner |
2000 | |
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats
ZY Jiang, YW Lin, A Clemont, EP Feener, KD Hein, M Igarashi, T Yamauchi, MF White, GL King |
Journal of Clinical Investigation | 1999 |
Could a high cholesterol diet cause Alzheimer's disease in Western Society? [Hypothesis]
RJ Holden |
Human Psychopharmacology: Clinical and Experimental | 1999 |
Role of protein tyrosine phosphatase-1B in diabetes and obesity
BP Kennedy |
Biomedicine & Pharmacotherapy | 1999 |
Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus
A Cheung, J Kusari, D Jansen, D Bandyopadhyay, A Kusari, M Bryer-Ash |
Journal of Laboratory and Clinical Medicine | 1999 |
Microtiter Well Assays for Protein Tyrosine Phosphatase Activities Directed against Phosphorylated Insulin Receptor or Insulin Receptor Substrate-1
J Krützfeldt, A Grünweller, W Raasch, M Drenckhan, HH Klein |
Analytical Biochemistry | 1999 |
Insulin-inducible changes in the relative ratio of PTP1B splice variants
SM Sell, D Reese |
Molecular Genetics and Metabolism | 1999 |
G-protein-coupled, extracellular Ca(2+)-sensing receptor: a versatile regulator of diverse cellular functions
J Fox, MA Miller, GB Stroup, EF Nemeth, SC Miller |
Vitamins and hormones | 1999 |
Tumor necrosis factor-α: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review)
RJ Holden, IS Pakula, PA Mooney |
Medical Hypotheses | 1999 |
The p53 paradox in the pathogenesis of tumor progression
RJ Holden, PA Mooney |
Medical Hypotheses | 1999 |
Insulin Signalling
FH Nystrom, MJ Quon |
Cellular Signalling | 1999 |
Structure-Based Discovery of Small Molecule Inhibitors Targeted to Protein Tyrosine Phosphatase 1B
M Sarmiento, L Wu, YF Keng, L Song, Z Luo, Z Huang, GZ Wu, AK Yuan, ZY Zhang |
Journal of Medicinal Chemistry | 1999 |
Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay
Y Okada |
Diabetes Research and Clinical Practice | 1998 |
Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1
A Sorokin, E Reed |
Biochemical Journal | 1998 |
Potent non-peptidyl inhibitors of protein tyrosine phosphatase 1B
SD Taylor, CC Kotoris, AN Dinaut, Q Wang, C Ramachandran, Z Huang |
Bioorganic & Medicinal Chemistry | 1998 |
Principles of Perinatal—Neonatal Metabolism
RM Cowett |
1998 | |
Insulin Action
AK Srivastava, BI Posner |
1998 | |
A Phosphotyrosyl Mimetic Peptide Reverses Impairment of Insulin-Stimulated Translocation of GLUT4 Caused by Overexpression of PTP1B in Rat Adipose Cells
H Chen, LN Cong, Y Li, ZJ Yao, L Wu, ZY Zhang, TR Burke, MJ Quon |
Biochemistry | 1998 |
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction
J C Byon, A B Kusari, J Kusari |
Molecular and Cellular Biochemistry | 1998 |
Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes
F Ahmad, JL Azevedo, R Cortright, GL Dohm, BJ Goldstein |
Journal of Clinical Investigation | 1997 |
Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue
F Ahmad, RV Considine, TL Bauer, JP Ohannesian, CC Marco, BJ Goldstein |
Metabolism | 1997 |
Expression of protein-tyrosine phosphatases in the major insulin target tissues
K Norris, F Norris, DH Kono, H Vestergaard, O Pedersen, AN Theofilopoulos, NP Møller |
FEBS Letters | 1997 |
Protein-tyrosine Phosphatases PTP1B and Syp Are Modulators of Insulin-stimulated Translocation of GLUT4 in Transfected Rat Adipose Cells
H Chen, SJ Wertheimer, CH Lin, SL Katz, KE Amrein, P Burn, MJ Quon |
The Journal of biological chemistry | 1997 |
Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin
D Bandyopadhyay, A Kusari, KA Kenner, F Liu, J Chernoff, TA Gustafson, J Kusari |
The Journal of biological chemistry | 1997 |
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects
D Worm, J Vinten, P Staehr, JE Henriksen, A Handberg, H Beck-Nielsen |
Diabetologia | 1996 |
Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling
KA Kenner, E Anyanwu, JM Olefsky, J Kusari |
The Journal of biological chemistry | 1996 |
A Peptide-based Protein-tyrosine Phosphatase Inhibitor Specifically Enhances Insulin Receptor Function in Intact Cells
HK Kole, MJ Garant, S Kole, M Bernier |
The Journal of biological chemistry | 1996 |
Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence
D Worm, A Handberg, E Hoppe, J Vinten, H Beck-Nielsen |
Diabetologia | 1996 |
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.
Worm D, Vinten J, Staehr P, Henriksen JE, Handberg A, Beck-Nielsen H |
Diabetologia | 1996 |
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects
LJ Goodyear, F Giorgino, LA Sherman, J Carey, RJ Smith, GL Dohm |
Journal of Clinical Investigation | 1995 |
Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects
F Ahmad, RV Considine, BJ Goldstein |
Journal of Clinical Investigation | 1995 |
Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor
J Sredy, DR Sawicki, BR Flam, D Sullivan |
Metabolism | 1995 |
Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus
F Ahmad, BJ Goldstein |
Metabolism | 1995 |
Thiazolidine Derivatives Ameliorate High Glucose-induced Insulin Resistance via the Normalization of Protein-tyrosine Phosphatase Activities
H Maegawa, R Ide, M Hasegawa, S Ugi, K Egawa, M Iwanishi, R Kikkawa, Y Shigeta, A Kashiwagi |
The Journal of biological chemistry | 1995 |